Contineum Therapeutics (CTNM) Payables (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Payables of $505000.0 for Q2 2026, down 74.76% year-over-year from $2.0 million in Q2 2025, and down 66.22% quarter-over-quarter from $1.5 million in Q1 2026.
Contineum Therapeutics (CTNM) Payables (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Payables history runs 4 years deep, the most recent figure standing at $505000.0 for Q2 2026.
- In Q2 2026, Payables fell 74.76% year-over-year to $505000.0; the TTM figure through Jun 2026 stood at $505000.0 (down 74.76% YoY), while the FY2025 annual figure was $1.0 million, down 43.9% from the prior year.
- Payables for Q2 2026 stood at $505000.0, down from $1.5 million in the prior quarter.
- The five-year high for Payables was $3.6 million in Q1 2025, with the low at $505000.0 in Q2 2026.
- The 4-year median for Payables is $1.0 million (2025), against an average of $1.3 million.
- The sharpest annual moves came in 2025 and 2026: Payables jumped 539.47% in 2025, then sank 74.76% in 2026.
- Contineum Therapeutics' Payables stood at $635000.0 in 2023, then soared by 185.2% to $1.8 million in 2024, then plunged by 43.9% to $1.0 million in 2025, then tumbled by 50.3% to $505000.0 in 2026.
- Business Quant data shows CTNM's Payables at $505000.0 in Q2 2026, $1.5 million in Q1 2026, and $1.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | 505,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 505,000.00 |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 786,000.00 |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 734,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Dec 31, 2023 | 635,000.00 |